Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Maeda, Yoshinobu  [Clear All Filters]
2024
Nakagawa S-I, Nukii Y, Mochizuki K, Uchiyama A, Maeda Y, Kurokawa T. A case of peripheral T-cell lymphoma in which therapy-related myelodysplastic syndrome developed and a second autologous transplantation was performed. J Clin Exp Hematop. 2024.
Saeki K, Fujiwara H, Seike K, Kuroi T, Nishimori H, Tanaka T, Matsuoka K-I, Fujii N, Maeda Y. Sigle Agent of Posttransplant Cyclophosphamide Without Calcineurin Inhibitor Controls Severity of Experimental Chronic GVHD. Acta Med Okayama. 2024;78(2):123-134.
2023
Sumii Y, Fujii K, Kondo T, Urata T, Kimura M, Fujiwara H, Asada N, Ennishi D, Nishimori H, Matsuoka K-I, et al. Evaluating the efficiency and safety of large-volume leukapheresis using the Spectra Optia continuous mononuclear cell collection protocol for peripheral blood stem cell collection from healthy donors: A retrospective study. Transfusion. 2023.
Iwamuro M, Kondo T, Ennishi D, Fujii N, Matsuoka K-I, Takahashi T, Hirabata A, Tanaka T, Otsuka F, Maeda Y, et al. Feasibility of Flow Cytometry Analysis of Gastrointestinal Tract-Residing Lymphocytes in Hematopoietic Stem Cell Transplant Recipients. Acta Med Okayama. 2023;77(4):347-357.
Sumii Y, Kondo T, Ikegawa S, Fukumi T, Iwamoto M, Nishimura MFiliz, Sugiura H, Sando Y, Nakamura M, Meguri Y, et al. Hematopoietic stem cell-derived Tregs are essential for maintaining favorable B cell lymphopoiesis following posttransplant cyclophosphamide. JCI Insight. 2023;8(8).
Komura A, Meguri Y, Matsubara C, Fujiwara H, Yukawa R, Hayashino K, Nakamura M, Yoshida C, Yamamoto K, Matsuoka K-I, et al. [Myelodysplastic syndrome with der (1;7)(q10;p10) complicated with eosinophilia and organizing pneumonia]. Rinsho Ketsueki. 2023;64(7):619-625.
2022
Kambara Y, Fujii N, Usui Y, Yamamoto A, Higo H, Fujiwara H, Asada N, Ennishi D, Nishimori H, Fujii K, et al. Association between early corticosteroid administration and long-term survival in non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2022.
Kitamura W, Fujii N, Nawa Y, Fujishita K, Sugiura H, Yoshioka T, Fujiwara Y, Usui Y, Fujii K, Fujiwara H, et al. Possible prognostic impact of WT1 mRNA expression at day + 30 after haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for patients with myeloid neoplasm: a multicenter study from the Okayama Hematological S. Int J Hematol. 2022.
2016
Murayama T, Fukuda T, Okumura H, Sunami K, Sawazaki A, Maeda Y, Tsurumi H, Uike N, Hidaka T, Takatsuka Y, et al. Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04. Int J Hematol. 2016.
2014
Kanda J, Ichinohe T, Fuji S, Maeda Y, Ohashi K, Fukuda T, Miyamura K, Iwato K, Eto T, Nakamae H, et al. The impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: A retrospective analysis from the JSHCT. Biol Blood Marrow Transplant. 2014.